Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks

Many studies estimate individuals’ values for avoiding fatality risks; however, most value-of-statistical-life studies focus on accident-related deaths. Consequently, little is known about preferences for avoiding other fatal risks, such as cancer. Cancer may engender strong feelings of dread, leading to a “cancer premium,” but cancer latency periods may have the opposite effect. Using a national survey, we elicit relative preferences for avoiding fatal cancer and auto-accident risks. We find strong preferences for avoiding cancer risks. With a 5-year latency, they are valued roughly three times greater than immediate accident risks, declining to 50% greater for a 25-year latency.

[1]  D. Hamermesh,et al.  Expectations, Life Expectancy, and Economic Behavior , 1985 .

[2]  P. Shackley,et al.  The impact of information on non-health attributes on willingness to pay for multiple health care programmes. , 2004, Social science & medicine.

[3]  J. Deshazo,et al.  An Empirical Model of Demand for Future Health States when Valuing Risk-Mitigating Programs , 2004 .

[4]  Anna Alberini,et al.  Willingness to pay for mortality risk reductions: Does latency matter? , 2004 .

[5]  H. Gibb,et al.  Procedures for calculating cessation lag. , 2003, Regulatory toxicology and pharmacology : RTP.

[6]  P. Shackley,et al.  Should we use willingness to pay to elicit community preferences for health care? New evidence from using a 'marginal' approach. , 2002, Journal of health economics.

[7]  Joseph E. Aldy,et al.  The Value of a Statistical Life: A Critical Review of Market Estimates Throughout the World , 2003 .

[8]  G. Dranitsaris.  PAMIDRONATE FOR THE PREVENTION OF SKELETAL- RELATED EVENTS IN MULTIPLE MYELOMA , 1999, International Journal of Technology Assessment in Health Care.

[9]  Ron Goeree,et al.  Age, Health and the Willingness to Pay for Mortality Risk Reductions: A Contingent Valuation Survey of Ontario Residents , 2002 .

[10]  Stephen M. Johnson,et al.  Insensitivity to the Value of Human Life: A Study of Psychophysical Numbing , 1997 .

[11]  Joel Huber,et al.  Pricing environmental health risks: survey assessments of risk-risk and risk-dollar trade-offs for chronic bronchitis☆ , 1991 .

[12]  E. Bradley,et al.  Self-Rated Life Expectancy as a Predictor of Mortality: Evidence from the HRS and AHEAD Surveys , 2003, Gerontology.

[13]  Trudy Ann Cameron,et al.  Efficient Estimation Methods for "Closed-ended' Contingent Valuation Surveys , 1987 .

[14]  Joel Huber,et al.  A Reference Lottery Metric for Valuing Health , 1996 .

[15]  S. Busch,et al.  Survival expectations of the obese: Is excess mortality reflected in perceptions? , 2005, Obesity research.

[16]  Maureen L. Cropper,et al.  The effect of information on health risk valuations , 1992 .

[17]  J. Moatti,et al.  Eliciting several willingness to pay in a single contingent valuation survey: application to health care. , 2003, Health economics.

[18]  Kenji Takeuchi,et al.  A Choice Experiment Approach to the Valuation of Mortality , 2005 .

[19]  James K. Hammitt,et al.  Effects of Disease Type and Latency on the Value of Mortality Risk , 2003 .

[20]  J. Baron,et al.  Confusion of Relative and Absolute Risk in Valuation , 1997 .

[21]  F. Sloan,et al.  Longevity Expectations and Death: Can People Predict Their Own Demise? , 2001 .

[22]  G. C. Morrison,et al.  Demand for health care in Denmark: results of a national sample survey using contingent valuation. , 2001, Social science & medicine.